Evidence map›Paper›PMID 40771474›Full record

ArticleFrontiers in medicine2025

Case Report: Liquid-based cytology diagnosis of pulmonary mucormycosis.

Shuai Luo, Xiaoxue Tian, Ting Xu, Yao Li, Qing Ji, Jinjing Wang

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shuai LuoDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Xiaoxue TianDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Ting XuDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Yao LiDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Qing JiDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Jinjing WangDepartment of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mucormycosis is an infrequent yet life-threatening opportunistic fungal infection, typically secondary to diabetic ketoacidosis. Owing to its non-specific clinical presentation and auxiliary test findings, timely diagnosis remains difficult. While fungal culture, direct smear, histopathological biopsy, and molecular diagnostic techniques are available, cytological evaluation and histopathological biopsy remain the principal modalities in clinical settings. Notably, cytological identification of mucorales remains rare. Case presentation: A 41-year-old male presented with a 20-day history of productive cough and fever, accompanied by a recent onset of hemoptysis. His medical history included type 2 diabetes mellitus. Diagnostic confirmation of mucormycosis was achieved through conventional cytological smear, liquid-based cytology, cell block preparation, tissue biopsy, and specialized staining techniques. Pulmonary mucormycosis was ultimately diagnosed. Conclusion: This report documents a case of pulmonary mucormycosis identified via conventional cytological smear, liquid-based cytology, and cell block preparation. Liquid-based cytology and cell block techniques offered a non-invasive and more expedient approach, highlighting their value in the early identification and intervention of mucormycosis.

Indexed as

cytologydiagnosisdifferential diagnosisliquid based cytologymucormycosis

Identifiers

PMID40771474
PMCPMC12325030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.